Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | BMEA |
---|---|---|
09:32 ET | 40422 | 4.42 |
09:34 ET | 7157 | 4.42 |
09:36 ET | 87581 | 4.39 |
09:38 ET | 70341 | 4.33 |
09:39 ET | 868 | 4.31 |
09:41 ET | 301 | 4.32 |
09:43 ET | 541 | 4.315 |
09:45 ET | 816 | 4.3 |
09:48 ET | 6681 | 4.28 |
09:50 ET | 2918 | 4.27 |
09:52 ET | 3317 | 4.27 |
09:54 ET | 57158 | 4.21 |
09:56 ET | 7888 | 4.186 |
09:57 ET | 5525 | 4.17 |
09:59 ET | 11941 | 4.21 |
10:01 ET | 200 | 4.186 |
10:03 ET | 3162 | 4.19 |
10:06 ET | 1331 | 4.19 |
10:08 ET | 1387 | 4.19 |
10:10 ET | 1637 | 4.2 |
10:12 ET | 950 | 4.2 |
10:14 ET | 2553 | 4.23 |
10:15 ET | 1832 | 4.25 |
10:17 ET | 8278 | 4.28 |
10:19 ET | 400 | 4.31 |
10:21 ET | 450 | 4.3 |
10:24 ET | 542 | 4.31 |
10:26 ET | 4497 | 4.31 |
10:28 ET | 4478 | 4.33 |
10:30 ET | 1350 | 4.33 |
10:32 ET | 1009 | 4.33 |
10:33 ET | 884 | 4.3301 |
10:35 ET | 410 | 4.33 |
10:37 ET | 313 | 4.33 |
10:39 ET | 6597 | 4.35 |
10:42 ET | 4602 | 4.335 |
10:44 ET | 1386 | 4.34 |
10:46 ET | 300 | 4.34 |
10:48 ET | 1850 | 4.34 |
10:50 ET | 400 | 4.345 |
10:51 ET | 1362 | 4.335 |
10:53 ET | 1589 | 4.34 |
10:57 ET | 600 | 4.3442 |
11:00 ET | 1750 | 4.345 |
11:02 ET | 1800 | 4.34 |
11:04 ET | 700 | 4.345 |
11:06 ET | 1132 | 4.355 |
11:08 ET | 3257 | 4.345 |
11:09 ET | 300 | 4.345 |
11:11 ET | 664 | 4.3402 |
11:13 ET | 3454 | 4.345 |
11:15 ET | 3122 | 4.36 |
11:18 ET | 1200 | 4.34 |
11:20 ET | 500 | 4.34 |
11:22 ET | 5103 | 4.33 |
11:24 ET | 1250 | 4.335 |
11:26 ET | 4534 | 4.3477 |
11:29 ET | 300 | 4.34 |
11:31 ET | 250 | 4.3401 |
11:33 ET | 1049 | 4.345 |
11:36 ET | 100 | 4.34 |
11:40 ET | 400 | 4.34 |
11:42 ET | 100 | 4.33 |
11:44 ET | 100 | 4.35 |
11:45 ET | 750 | 4.345 |
11:47 ET | 300 | 4.345 |
11:49 ET | 400 | 4.33 |
11:51 ET | 2768 | 4.35 |
11:54 ET | 3777 | 4.34 |
11:56 ET | 400 | 4.34 |
11:58 ET | 300 | 4.34 |
12:00 ET | 3896 | 4.33 |
12:02 ET | 219 | 4.32 |
12:03 ET | 1716 | 4.27 |
12:05 ET | 2473 | 4.265 |
12:07 ET | 985 | 4.26 |
12:09 ET | 1300 | 4.26 |
12:12 ET | 3100 | 4.26 |
12:14 ET | 900 | 4.26 |
12:16 ET | 2423 | 4.25 |
12:18 ET | 500 | 4.25 |
12:20 ET | 200 | 4.25 |
12:21 ET | 3620 | 4.25 |
12:23 ET | 300 | 4.255 |
12:25 ET | 2168 | 4.25 |
12:27 ET | 887 | 4.25 |
12:30 ET | 3012 | 4.24 |
12:32 ET | 800 | 4.24 |
12:34 ET | 1700 | 4.23 |
12:36 ET | 3157 | 4.23 |
12:38 ET | 218 | 4.22 |
12:39 ET | 2198 | 4.23 |
12:41 ET | 2100 | 4.23 |
12:43 ET | 400 | 4.22 |
12:45 ET | 695 | 4.22 |
12:48 ET | 3770 | 4.205 |
12:50 ET | 650 | 4.205 |
12:52 ET | 8860 | 4.2 |
12:54 ET | 250 | 4.21 |
12:56 ET | 1923 | 4.21 |
12:57 ET | 1080 | 4.21 |
12:59 ET | 826 | 4.2 |
01:01 ET | 8254 | 4.23 |
01:03 ET | 1700 | 4.2109 |
01:06 ET | 8794 | 4.25 |
01:08 ET | 6557 | 4.2498 |
01:10 ET | 7449 | 4.25 |
01:12 ET | 5300 | 4.2497 |
01:14 ET | 400 | 4.24 |
01:15 ET | 906 | 4.2307 |
01:17 ET | 2210 | 4.23 |
01:19 ET | 1032 | 4.23 |
01:21 ET | 200 | 4.225 |
01:24 ET | 1250 | 4.22 |
01:26 ET | 835 | 4.2201 |
01:28 ET | 2789 | 4.23 |
01:30 ET | 300 | 4.23 |
01:32 ET | 717 | 4.23 |
01:33 ET | 514 | 4.22 |
01:35 ET | 886 | 4.23 |
01:37 ET | 100 | 4.22 |
01:39 ET | 4450 | 4.23 |
01:42 ET | 2200 | 4.23 |
01:44 ET | 1200 | 4.23 |
01:46 ET | 400 | 4.24 |
01:48 ET | 400 | 4.24 |
01:50 ET | 522 | 4.23 |
01:51 ET | 3448 | 4.24 |
01:55 ET | 1160 | 4.235 |
01:57 ET | 2744 | 4.26 |
02:00 ET | 400 | 4.25 |
02:02 ET | 1305 | 4.25 |
02:04 ET | 1036 | 4.25 |
02:06 ET | 700 | 4.255 |
02:08 ET | 2430 | 4.24 |
02:09 ET | 500 | 4.24 |
02:11 ET | 506 | 4.24 |
02:13 ET | 1606 | 4.24 |
02:15 ET | 500 | 4.25 |
02:18 ET | 300 | 4.23 |
02:20 ET | 1853 | 4.24 |
02:22 ET | 702 | 4.23 |
02:24 ET | 4216 | 4.24 |
02:26 ET | 200 | 4.24 |
02:27 ET | 300 | 4.23 |
02:29 ET | 1200 | 4.23 |
02:31 ET | 500 | 4.23 |
02:33 ET | 950 | 4.23 |
02:36 ET | 1000 | 4.23 |
02:38 ET | 2560 | 4.24 |
02:40 ET | 1151 | 4.23 |
02:42 ET | 400 | 4.23 |
02:44 ET | 1284 | 4.23 |
02:45 ET | 320 | 4.23 |
02:47 ET | 3151 | 4.23 |
02:49 ET | 9370 | 4.24 |
02:51 ET | 1000 | 4.235 |
02:54 ET | 5708 | 4.24 |
02:56 ET | 710 | 4.24 |
02:58 ET | 1003 | 4.24 |
03:00 ET | 3567 | 4.2401 |
03:02 ET | 1695 | 4.245 |
03:03 ET | 3211 | 4.24 |
03:05 ET | 8871 | 4.235 |
03:07 ET | 1800 | 4.23 |
03:09 ET | 18452 | 4.195 |
03:12 ET | 1400 | 4.2 |
03:14 ET | 3735 | 4.2 |
03:16 ET | 600 | 4.19 |
03:18 ET | 734 | 4.19 |
03:20 ET | 300 | 4.2 |
03:21 ET | 400 | 4.19 |
03:23 ET | 643 | 4.19 |
03:25 ET | 950 | 4.19 |
03:27 ET | 1058 | 4.19 |
03:30 ET | 1426 | 4.19 |
03:32 ET | 800 | 4.195 |
03:34 ET | 2501 | 4.2 |
03:36 ET | 1562 | 4.2 |
03:38 ET | 806 | 4.2 |
03:39 ET | 768 | 4.2 |
03:41 ET | 5804 | 4.2 |
03:43 ET | 1650 | 4.205 |
03:45 ET | 5006 | 4.215 |
03:48 ET | 1957 | 4.215 |
03:50 ET | 5676 | 4.215 |
03:52 ET | 5835 | 4.225 |
03:54 ET | 8994 | 4.23 |
03:56 ET | 10261 | 4.24 |
03:57 ET | 15296 | 4.25 |
03:59 ET | 32055 | 4.23 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Biomea Fusion Inc | 152.0M | -1.2x | --- |
Ventyx Biosciences Inc | 153.7M | -0.7x | --- |
Achieve Life Sciences Inc | 155.9M | -3.5x | --- |
INmune Bio Inc | 154.9M | -4.1x | --- |
Vigil Neuroscience Inc | 151.5M | -1.9x | --- |
Elevation Oncology Inc | 155.7M | -2.8x | --- |
Biomea Fusion, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery and development of oral covalent small molecules to treat patients with metabolic diseases and genetically defined cancers. A covalent small molecule is a synthetic compound that forms a permanent bond to its target protein. The Company is utilizing its proprietary FUSION System to discover, design and develop a pipeline of covalent-binding small molecule medicines designed to maximize clinical benefit for patients. Its lead product candidate, BMF-219, is designed to be an oral, potent, and selective covalent inhibitor of menin, built from its FUSION System. It is developing BMF-219 for the treatment of menin regulated or dependent diseases, such as type 1 and type 2 diabetes as well as subtypes of liquid and solid tumors. Its second development candidate, BMF-500, a covalent inhibitor of activating mutations of the FMS-like tyrosine kinase 3 (FLT3).
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $152.0M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 35.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-3.57 |
Book Value | $4.72 |
P/E Ratio | -1.2x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.